Email this article Prostate cancer: some aspects of epidemiology, etiology and carcinogenesis for prostate cancer
- Authors: Al-Shukri S.K.1, Borovets S.Y.1
-
Affiliations:
- St.-Petersburg State Medical University named after acad. I. P. Pavlov
- Issue: Vol 2, No 1 (2012)
- Pages: 23-25
- Section: Articles
- URL: https://journals.rcsi.science/uroved/article/view/2547
- DOI: https://doi.org/10.17816/uroved2123-25
- ID: 2547
Cite item
Open Access
Access granted
Subscription Access
Abstract
In the literature review some modern data concerning epidemiology, etiology and carcinogenesis for prostate cancer are contained based on the Russian and foreign scientific sources.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Salman Khasunovich Al-Shukri
St.-Petersburg State Medical University named after acad. I. P. Pavlov
Email: al-shukri@mail.ru
doctor of medical science, professor, head of the department. Department of Urology
Sergey Yur'evich Borovets
St.-Petersburg State Medical University named after acad. I. P. Pavlov
Email: sborovets@mail.ru
doctor of medical science. Department of Urology
References
- Давыдов М. И., Аксель Е. М. Статистика злокачественных новообразований в России и странах СНГ в 2004 году // Вестник РОНЦ им. Н. Н. Блохина РАМН. 2006. Т. 17, № 3. — 132 с.
- Аль-Шукри С. Х., Боровец С. Ю. Значимость мутаций гена BRG1 при рецидивировании рака предстательной железы после радикальной простатэктомии // Пленум правления Российского общества урологов: Материалы. Тюмень, 2005. С. 444.
- Аль-Шукри С. Х., Ткачук В. Н. Опухоли мочеполовых органов: Руководство для врачей. СПб.: Питер, 2000. 309 с.
- Al-Hajj M., Clarke M. F. Self-renewal and solid tumor stem cells // Oncogene. 2004. Vol. 23, № 43. P. 7274–7282.
- De Marzo A. M., Nelson W. G., Isaacs W. B., Epstein J. I. Pathological and molecular aspects of prostate cancer // Lancet. 2003. Vol. 361, Part 9361. P. 955–964.
- Dennis L. K., Lynch C. F., Torner J. C. Epidemiologic association between prostatitis and prostate cancer // Urology. 2002. Vol. 60, № 1. P. 78–83.
- Fox W. D., Higgins B., Maiese K. M. et al. Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer // Clin. Cancer. Res. 2002. № 8. P. 3226–3231.
- Gittes R. F. Carcinoma of the prostate // N. Engl. J. Med. 1991. P. 1892–1893.
- Hanahan D., Weinberg R. A. The hallmarks of cancer // Cell. 2000. Vol. 7, № 100. P. 57–70.
- Hara T., Miyazaki H., Lee A. et al. Androgen receptor and invasion in prostate cancer // Cancer Res. 2008. Vol. 68, № 4. P. 1128–1135.
- Jemal A., Clegg L. X., Ward E. et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival // Cancer. 2004. Vol. 101, № 1. P. 3–27.
- Massard C., Deutch E., Soria J. Tumor stem cell-targeted treatment: limination or differentiation // Ann Oncol. 2006. Vol. 17, № 11. P. 1620–1624.
- Mimeault M., Batra S. K. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies // Carcinogenesis. 2006. Vol. 27, № 1. P. 1–22.
- McNeal J. E., Alroy J., Leav I. et al. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis // Am. J. Clin. Pathol. 1988. Vol. 90, № 2. P. 23–32.
- Platz E. A., De Marzo A. M. Epidemiology of inflammation and prostate cancer // J. Urol. 2004. Vol. 171, № 2. P. 36–40.
- Sakr W. A., Billis A., Ekman P. et al. Epidemiology of high-grade prostatic intraepithelial neoplasia // Scand. J. Urol. Nephrol. 2000. Vol. 205, № 1. P. 11–18.
- Wingo P. A., Tong T., Bolden S. Cancer statistics // Cancer. J. Clin. 1995. Vol. 45, № 1. P. 8–30.
- Wingo P. A., Tong T., Bolden S. Cancer statistics // Cancer. J. Clin. 1995. Vol. 45, № 2. P. 127–128.
